资讯
EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a studyIn phase 2a study, brivekimig led to clinically ...
EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果